Cathflo Activase 2mg Alteplase

Manufacturer GENENTECH Active Ingredient Alteplase (Catheter Clearance)(AL te plase) Pronunciation AL-te-plase
It is used to clear blood clots out of catheters.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Thrombolytic
đŸ§Ŧ
Pharmacologic Class
Tissue Plasminogen Activator (tPA)
🤰
Pregnancy Category
Category C
✅
FDA Approved
May 2001
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Cathflo Activase is a medicine used to clear blockages in central venous catheters (like PICC lines or port-a-caths). These blockages are often caused by tiny blood clots. This medicine helps dissolve those clots so your catheter can work properly again for infusions or blood draws.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to follow the instructions carefully. This medication is administered directly into a catheter.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the best storage method.

Missing a Dose

This medication is typically given as needed in a healthcare setting, so you won't need to worry about missing a dose at home. However, if you have any concerns about your medication schedule, be sure to discuss them with your healthcare provider.
💡

Lifestyle & Tips

  • Report any unusual bleeding or bruising immediately.
  • Avoid vigorous activity that could dislodge the catheter or cause bleeding at the insertion site.
  • Follow all instructions from your healthcare provider regarding catheter care.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 2 mg in 2 mL solution instilled into the occluded catheter lumen
Dose Range: 2 - 2 mg

Condition-Specific Dosing:

catheter_occlusion: Instill 2 mg in 2 mL solution into the occluded catheter lumen. After 30 minutes, assess catheter function. If function not restored, allow to dwell for 120 minutes. If function still not restored, a second dose may be instilled.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established (limited data, use with caution)
Infant: For patients weighing <10 kg: 110% of the internal lumen volume of the catheter, not to exceed 1 mg in 1 mL. For patients weighing â‰Ĩ10 kg: 2 mg in 2 mL solution. Max 2 mg per lumen.
Child: For patients weighing <10 kg: 110% of the internal lumen volume of the catheter, not to exceed 1 mg in 1 mL. For patients weighing â‰Ĩ10 kg: 2 mg in 2 mL solution. Max 2 mg per lumen.
Adolescent: 2 mg in 2 mL solution instilled into the occluded catheter lumen.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed
Moderate: No specific adjustment needed
Severe: No specific adjustment needed
Dialysis: No specific adjustment needed; monitor for bleeding

Hepatic Impairment:

Mild: No specific adjustment needed
Moderate: No specific adjustment needed
Severe: No specific adjustment needed

Pharmacology

đŸ”Ŧ

Mechanism of Action

Alteplase is a recombinant human tissue-type plasminogen activator (tPA). It binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin. Plasmin then initiates local fibrinolysis by degrading fibrin, fibrinogen, and other plasma proteins. For catheter clearance, this action helps dissolve fibrin clots causing occlusion.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (intravenous/intraluminal administration)
Tmax: Immediate (after IV bolus)
FoodEffect: Not applicable (IV/intraluminal administration)

Distribution:

Vd: Approximately 5-6 L (similar to plasma volume)
ProteinBinding: Low (<50%)
CnssPenetration: Limited

Elimination:

HalfLife: Initial half-life: ~5 minutes; Terminal half-life: ~30 minutes
Clearance: Approximately 550-650 mL/min
ExcretionRoute: Primarily hepatic
Unchanged: Negligible
âąī¸

Pharmacodynamics

OnsetOfAction: Within 30 minutes (for catheter clearance)
PeakEffect: Within 30-120 minutes (for catheter clearance)
DurationOfAction: Short (due to rapid clearance, but effect on clot can be sustained)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Note: In rare cases, allergic reactions can be fatal.
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding from the gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that enlarge
+ Uncontrollable bleeding
Neurological symptoms, such as:
+ Weakness on one side of the body
+ Difficulty speaking or thinking
+ Changes in balance
+ Drooping on one side of the face
+ Blurred vision
Severe headache
Severe stomach pain
Redness, swelling, or pain at the catheter site
* Swelling, warmth, numbness, color changes, or pain in a leg or arm

Other Possible Side Effects

Like all medications, this drug can cause side effects. However, many people do not experience any side effects or only have mild ones. If you have side effects that bother you or persist, contact your doctor for guidance.

Please note that this list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor.

To report side effects, you can contact the FDA at 1-800-332-1088 or visit their website at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Any new or increased bleeding (e.g., from gums, nose, catheter site, blood in urine or stool)
  • Severe headache
  • Sudden weakness or numbness
  • Dizziness or fainting
  • Signs of allergic reaction (rash, itching, swelling, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about any allergies you have, including:
- An allergy to this medication or any of its components
- An allergy to other medications, foods, or substances
When discussing your allergies, be sure to describe the symptoms you experienced.

Additionally, this medication may interact with other medications or health conditions. To ensure safe use, it is crucial to:
- Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins
- Share information about any health problems you have
You must verify that it is safe to take this medication with all your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you are pregnant, planning to become pregnant, or are breast-feeding, be sure to discuss this with your doctor. You and your doctor will need to carefully weigh the benefits and risks of using this medication during pregnancy or breast-feeding to make an informed decision about its use.
🆘

Overdose Information

Overdose Symptoms:

  • Excessive bleeding (e.g., severe nosebleeds, prolonged bleeding from minor cuts, large bruises, blood in urine or stool, internal bleeding)

What to Do:

Immediately notify your healthcare provider. Management typically involves discontinuing the drug, applying pressure to bleeding sites, and potentially administering blood products (e.g., cryoprecipitate, fresh frozen plasma) if bleeding is severe. Call 911 or your local emergency number for severe symptoms.

Drug Interactions

🔴

Major Interactions

  • Anticoagulants (e.g., warfarin, heparin, direct oral anticoagulants): Increased risk of bleeding.
  • Antiplatelet agents (e.g., aspirin, clopidogrel, ticagrelor): Increased risk of bleeding.
  • Other thrombolytic agents: Increased risk of bleeding.
🟡

Moderate Interactions

  • NSAIDs (e.g., ibuprofen, naproxen): May increase risk of bleeding.
  • SSRIs/SNRIs: May increase risk of bleeding.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history for bleeding risk

Rationale: To identify contraindications or precautions for thrombolytic use.

Timing: Prior to administration

Catheter patency and signs of occlusion

Rationale: To confirm the need for treatment and assess baseline function.

Timing: Prior to administration

📊

Routine Monitoring

Signs of bleeding (e.g., oozing from insertion site, hematoma, epistaxis, hematuria)

Frequency: During and after administration, especially within the first 24 hours

Target: Absence of bleeding

Action Threshold: Any sign of bleeding should prompt immediate assessment and intervention.

Catheter function (e.g., aspiration, infusion)

Frequency: 30 minutes after instillation, then 120 minutes after instillation (if needed), and after aspiration of drug

Target: Restoration of catheter patency

Action Threshold: Failure to restore function after 120 minutes may indicate need for second dose or alternative intervention.

Vital signs (BP, HR, RR, Temp)

Frequency: Routinely as per institutional protocol

Target: Within normal limits

Action Threshold: Significant changes may indicate adverse reaction or bleeding.

đŸ‘ī¸

Symptom Monitoring

  • Unusual bleeding or bruising
  • Blood in urine or stools (dark or red)
  • Nosebleeds
  • Gum bleeding
  • Headache (severe or unusual)
  • Dizziness or lightheadedness
  • Weakness
  • Allergic reaction symptoms (rash, itching, hives, swelling, difficulty breathing)

Special Patient Groups

🤰

Pregnancy

Alteplase is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Systemic use has been associated with bleeding complications in the mother and fetus.

Trimester-Specific Risks:

First Trimester: Potential for bleeding complications; limited data.
Second Trimester: Potential for bleeding complications; limited data.
Third Trimester: Potential for bleeding complications, especially peripartum; limited data.
🤱

Lactation

Alteplase is considered L3 (moderately safe) for lactation. It has a very short half-life, making infant exposure through breast milk unlikely to be significant. Caution is advised, but breastfeeding may be continued with monitoring for infant bleeding.

Infant Risk: Low risk of adverse effects due to short half-life and poor oral bioavailability, but monitor for signs of bleeding.
đŸ‘ļ

Pediatric Use

Dosing for catheter clearance is established for pediatric patients based on weight and catheter lumen volume. Safety and efficacy have been demonstrated. Close monitoring for bleeding is crucial, especially in very young or low-weight infants.

👴

Geriatric Use

No specific dose adjustment is required based on age. However, elderly patients may have an increased risk of bleeding complications due to age-related physiological changes or concomitant medications. Monitor closely for signs of bleeding.

Clinical Information

💎

Clinical Pearls

  • Cathflo Activase is specifically formulated and dosed for intraluminal instillation to clear occluded central venous catheters, not for systemic thrombolysis.
  • Ensure proper instillation technique: instill the entire volume into the occluded lumen, do not force the solution, and allow it to dwell for the recommended time.
  • Aspirate the drug and residual clot after the dwell time to prevent systemic exposure.
  • If the catheter remains occluded after two doses, consider alternative methods for catheter clearance or replacement.
  • Always check for contraindications to thrombolytic therapy, even for local use, especially conditions that increase bleeding risk.
🔄

Alternative Therapies

  • Mechanical methods for catheter clearance (e.g., guidewire manipulation)
  • Catheter exchange or replacement
  • Ethanol lock (for some types of occlusions, e.g., lipid build-up, biofilm)
  • Urokinase (historically used, but no longer marketed in the US for this indication)
💰

Cost & Coverage

Average Cost: Price varies significantly by institution and contract per vial
Insurance Coverage: Specialty drug, typically covered under medical benefit for hospital/clinic administration. Outpatient coverage varies.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless specifically instructed to do so. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet, which your pharmacist can provide. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the quantity, and the time of ingestion.